• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病中的上皮-间充质转化。

Epithelial-mesenchymal transition in Crohn's disease.

机构信息

Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Inflammatory Bowel Disease Research Center; Renji Hospital, School of Medicine, Shanghai Jiao Tong University; Shanghai Institute of Digestive Disease, Shanghai, China.

出版信息

Mucosal Immunol. 2018 Mar;11(2):294-303. doi: 10.1038/mi.2017.107. Epub 2017 Dec 20.

DOI:10.1038/mi.2017.107
PMID:29346350
Abstract

Crohn's disease (CD) is often accompanied by the complications of intestinal strictures and fistulas. These complications remain obstacles in CD treatment. In recent years, the importance of epithelial-mesenchymal transition in the pathogenesis of CD-associated fistulas and intestinal fibrosis has become apparent. Epithelial-mesenchymal transition refers to a dynamic change, wherein epithelial cells lose their polarity and adherence and acquire migratory function and fibroblast features. During formation of CD-associated fistulas, intestinal epithelial cells dislocate from the basement membrane and migrate to the lining of the fistula tracts, where they convert into transitional cells as a compensatory response under the insufficient wound healing condition. In CD-associated intestinal fibrosis, epithelial-mesenchymal transition may serve as a source of new fibroblasts and consequently lead to overproduction of extracellular matrix. In this review, we present current knowledge of epithelial-mesenchymal transition and its role in the pathogenesis of CD in order to highlight new therapy targets for the associated complications.

摘要

克罗恩病(CD)常伴有肠狭窄和瘘管等并发症。这些并发症仍然是 CD 治疗的障碍。近年来,上皮-间充质转化在 CD 相关瘘管和肠纤维化发病机制中的重要性已变得明显。上皮-间充质转化是指一种动态变化,其中上皮细胞失去极性和黏附性,并获得迁移功能和成纤维细胞特征。在 CD 相关瘘管形成过程中,肠上皮细胞从基底膜脱落并迁移到瘘管衬里,在愈合条件不足的情况下,作为一种代偿反应,它们转化为过渡细胞。在 CD 相关肠纤维化中,上皮-间充质转化可能作为新成纤维细胞的来源,并导致细胞外基质的过度产生。在这篇综述中,我们介绍了上皮-间充质转化及其在 CD 发病机制中的作用的最新知识,以强调相关并发症的新治疗靶点。

相似文献

1
Epithelial-mesenchymal transition in Crohn's disease.克罗恩病中的上皮-间充质转化。
Mucosal Immunol. 2018 Mar;11(2):294-303. doi: 10.1038/mi.2017.107. Epub 2017 Dec 20.
2
Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.上皮-间充质转化在炎症性肠病中的作用。
J Crohns Colitis. 2019 Apr 26;13(5):659-668. doi: 10.1093/ecco-jcc/jjy201.
3
MiR-21 regulates epithelial-mesenchymal transition in intestinal fibrosis of Crohn's disease by targeting PTEN/mTOR.miR-21 通过靶向 PTEN/mTOR 调控克罗恩病肠纤维化中的上皮间质转化。
Dig Liver Dis. 2022 Oct;54(10):1358-1366. doi: 10.1016/j.dld.2022.04.007. Epub 2022 Apr 30.
4
Total flavone of suppresses epithelial-mesenchymal transition interfering transforming growth factor-β1 signaling in Crohn's disease intestinal fibrosis.总黄酮通过抑制转化生长因子-β1 信号通路抑制克罗恩病肠纤维化的上皮间质转化。
World J Gastroenterol. 2018 Aug 14;24(30):3414-3425. doi: 10.3748/wjg.v24.i30.3414.
5
Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development.琥珀酸通过 SUCNR1 激活肠上皮细胞中的 EMT:瘘管发展的新主角。
Cells. 2020 Apr 29;9(5):1104. doi: 10.3390/cells9051104.
6
Epithelial down-regulation of the miR-200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition.miR-200 家族在纤维狭窄性克罗恩病中的上皮下调与上皮-间充质转化的特征相关。
J Cell Mol Med. 2018 Nov;22(11):5617-5628. doi: 10.1111/jcmm.13836. Epub 2018 Sep 6.
7
A role for tumor necrosis factor and bacterial antigens in the pathogenesis of Crohn's disease-associated fistulae.肿瘤坏死因子和细菌抗原在克罗恩病相关瘘管发病机制中的作用。
Inflamm Bowel Dis. 2013 Dec;19(13):2878-87. doi: 10.1097/01.MIB.0000435760.82705.23.
8
Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosis.维生素 D 受体通过调节肠道纤维化中的上皮线粒体功能抑制 EMT。
J Biol Chem. 2021 Jan-Jun;296:100531. doi: 10.1016/j.jbc.2021.100531. Epub 2021 Mar 11.
9
Advanced Oxidation Protein Products Induce Epithelial-Mesenchymal Transition of Intestinal Epithelial Cells via a PKC δ-Mediated, Redox-Dependent Signaling Pathway.高级氧化蛋白产物通过蛋白激酶 Cδ 介导的、依赖氧化还原的信号通路诱导肠道上皮细胞上皮-间充质转化。
Antioxid Redox Signal. 2017 Jul 1;27(1):37-56. doi: 10.1089/ars.2015.6611. Epub 2016 Sep 30.
10
Diminished Vitamin D Receptor Protein Levels in Crohn's Disease Fibroblasts: Effects of Vitamin D.克罗恩病成纤维细胞中维生素 D 受体蛋白水平降低:维生素 D 的作用。
Nutrients. 2020 Apr 1;12(4):973. doi: 10.3390/nu12040973.

引用本文的文献

1
Epithelium dynamics differ in time and space when exposed to the permeation enhancers penetramax and EGTA. A head-to-head mechanistic comparison.当暴露于渗透促进剂Penetramax和EGTA时,上皮动力学在时间和空间上存在差异。一项直接的机制比较。
Front Drug Deliv. 2023 Aug 24;3:1221628. doi: 10.3389/fddev.2023.1221628. eCollection 2023.
2
Disease-Specific Novel Role of Growth Differentiation Factor 15 in Organ Fibrosis.生长分化因子15在器官纤维化中的疾病特异性新作用
Int J Mol Sci. 2025 Jun 14;26(12):5713. doi: 10.3390/ijms26125713.
3
Single-Cell and Spatial Multi-omics Reveal Interferon Signaling in the Pathogenesis of Perianal Fistulizing Crohn's Disease.

本文引用的文献

1
Organoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis perspective.基于类器官的上皮间质转化 (OEMT) 模型:从肠道纤维化角度看。
Sci Rep. 2017 May 26;7(1):2435. doi: 10.1038/s41598-017-02190-5.
2
Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.炎症性肠病中肠道纤维化的发病机制及治疗意义展望
Dig Dis. 2017;35(1-2):25-31. doi: 10.1159/000449079. Epub 2017 Feb 1.
3
Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
单细胞和空间多组学揭示肛周瘘管性克罗恩病发病机制中的干扰素信号传导
bioRxiv. 2024 Nov 10:2024.11.08.620717. doi: 10.1101/2024.11.08.620717.
4
Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review.植物化学物质作为炎症性肠病中肠纤维化的有前途的治疗方法:批判性评价。
Nutrients. 2024 Oct 25;16(21):3633. doi: 10.3390/nu16213633.
5
The Diagnosis of Intestinal Fibrosis in Crohn's Disease-Present and Future.克罗恩病肠纤维化的诊断——现状与未来。
Int J Mol Sci. 2024 Jun 25;25(13):6935. doi: 10.3390/ijms25136935.
6
Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease.用于模拟炎症性肠病纤维化的患者来源肠类器官的表征。
Inflamm Res. 2024 Aug;73(8):1359-1370. doi: 10.1007/s00011-024-01901-9. Epub 2024 Jun 6.
7
Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis.血清半乳糖凝集素-3 作为原发性硬化性胆管炎的非侵入性标志物。
Int J Mol Sci. 2024 Apr 27;25(9):4765. doi: 10.3390/ijms25094765.
8
Inhibition of Immunoproteasome Attenuates NLRP3 Inflammasome Response by Regulating E3 Ubiquitin Ligase TRIM31.抑制免疫蛋白酶体通过调节 E3 泛素连接酶 TRIM31 来减轻 NLRP3 炎性小体反应。
Cells. 2024 Apr 13;13(8):675. doi: 10.3390/cells13080675.
9
An model to study immune activation, epithelial disruption and stromal remodelling in inflammatory bowel disease and fistulising Crohn's disease.一种用于研究炎症性肠病和瘘管性克罗恩病中免疫激活、上皮破坏和基质重塑的模型。
Front Immunol. 2024 Feb 12;15:1357690. doi: 10.3389/fimmu.2024.1357690. eCollection 2024.
10
Role of Adipose Tissue Hormones in Pathogenesis of Cryptoglandular Anal Fistula.脂肪组织激素在肛隐窝型肛瘘发病机制中的作用。
Int J Mol Sci. 2024 Jan 25;25(3):1501. doi: 10.3390/ijms25031501.
过去二十年克罗恩病长期预后的改善及其与医疗管理变化的关系:基于人群的IBDSL队列研究结果
Am J Gastroenterol. 2017 Feb;112(2):325-336. doi: 10.1038/ajg.2016.524. Epub 2016 Dec 6.
4
MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases.微小RNA介导的纤维化疾病中的上皮-间质转化
Eur J Pharmacol. 2017 Feb 5;796:190-206. doi: 10.1016/j.ejphar.2016.12.003. Epub 2016 Dec 2.
5
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.Lebrikizumab 在未得到控制的哮喘患者中的疗效和安全性(LAVOLTA I 和 LAVOLTA II):复制,III 期,随机,双盲,安慰剂对照试验。
Lancet Respir Med. 2016 Oct;4(10):781-796. doi: 10.1016/S2213-2600(16)30265-X. Epub 2016 Sep 5.
6
Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD.细胞因子和抗细胞因子疗法在预防或治疗 IBD 纤维化中的应用。
United European Gastroenterol J. 2016 Aug;4(4):531-40. doi: 10.1177/2050640616649356. Epub 2016 May 10.
7
The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.Micro-429 通过靶向 ZEB1 和 CRKL 抑制宫颈癌细胞的作用。
Biomed Pharmacother. 2016 May;80:311-321. doi: 10.1016/j.biopha.2016.03.035. Epub 2016 Apr 5.
8
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells.不同的上皮-间质转化程序控制正常乳腺干细胞和肿瘤起始细胞。
Nature. 2015 Sep 10;525(7568):256-60. doi: 10.1038/nature14897. Epub 2015 Sep 2.
9
Biologic agents for IBD: practical insights.炎症性肠病的生物制剂治疗:实用见解。
Nat Rev Gastroenterol Hepatol. 2015 Sep;12(9):537-45. doi: 10.1038/nrgastro.2015.135. Epub 2015 Aug 18.
10
The multidisciplinary health care team in the management of stenosis in Crohn's disease.多学科医疗团队在克罗恩病狭窄管理中的作用
J Multidiscip Healthc. 2015 Mar 31;8:167-79. doi: 10.2147/JMDH.S38729. eCollection 2015.